Cardiac Magnetic Resonance Imaging for Stage B Heart Failure

被引：6

作者：

Partington, Sara L. ^{[2
,3
]}

Cheng, Susan ^{[4
]}

Lima, Joao A. C. ^{[1
,5
,6
]}

机构：

[1] Johns Hopkins Univ Hosp, Div Cardiol, Blalock Cardiol Div 524D, Baltimore, MD 21287 USA

[2] Brigham & Womens Hosp, Dept Med, Noninvas Cardiovasc Imaging Program, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Radiol, Noninvas Cardiovasc Imaging Program, Boston, MA 02115 USA

[4] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA

[5] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA

[6] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA

来源：

HEART FAILURE CLINICS | 2012年 / 8卷 / 02期

关键词：

Cardiac MRI; Heart failure; Stage B heart failure; ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; NEPHROGENIC SYSTEMIC FIBROSIS; DELAYED CONTRAST-ENHANCEMENT; HYPERTROPHIC CARDIOMYOPATHY; MICROVASCULAR OBSTRUCTION; SYSTOLIC DYSFUNCTION; DIABETIC-PATIENTS; TIME-COURSE; PERFUSION;

D O I：

10.1016/j.hfc.2011.11.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiac magnetic resonance imaging (CMR) can play a key role in the assessment and follow-up of patients with stage B heart failure. CMR currently serves as the reference standard for quantifying right and left ventricular size and ejection fraction. Technical advances have also enabled CMR to provide noninvasive tissue characterization and detailed assessments of myocardial performance. Thus, in addition to standard metrics of cardiac structure and function, CMR offers a variety of tools for determining cause, severity, and estimating the prognosis associated with an asymptomatic cardiomyopathy.

引用

页码：179 / +

页数：13

共 61 条

[1] Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy on relation to delayed enhancement on cardiovascular magnetic resonance [J].

Adabag, A. Selcuk ;

Maron, Barry J. ;

Appelbaum, Evan ;

Harrigan, Caltlin J. ;

Buros, Jacqueline L. ;

Gibson, C. Michael ;

Lesser, John R. ;

Hanna, Constance A. ;

Udelson, James E. ;

Manning, Warren J. ;

Maron, Martin S. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (14) :1369-1374

[2] Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging - Histopathological and displacement encoding with stimulated echoes (DENSE) functional validations [J].

Aletras, AH ;

Tilak, GS ;

Natanzon, A ;

Hsu, LY ;

Gonzalez, FM ;

Hoyt, RF ;

Arai, AE .

CIRCULATION, 2006, 113 (15) :1865-1870

[3] Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis [J].

Allman, KC ;

Shaw, LJ ;

Hachamovitch, R ;

Udelson, JE .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1151-1158

[4] Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy [J].

Assomull, Ravi G. ;

Prasad, Sanjay K. ;

Lyne, Jonathan ;

Smith, Gillian ;

Burman, Elizabeth D. ;

Khan, Mohammed ;

Sheppard, Mary N. ;

Poole-Wilson, Philip A. ;

Pennell, Dudley J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (10) :1977-1985

[5] Cardiac imaging to identify patients at risk for developing heart failure after myocardial infarction. [J].

Azevedo C.F. ;

Cheng S. ;

Lima J.A. .

Current Heart Failure Reports, 2005, 2 (4) :183-188

[6] Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization [J].

Baer, FM ;

Theissen, P ;

Schneider, CA ;

Voth, E ;

Sechtem, U ;

Schicha, H ;

Erdman, E .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (05) :1040-1048

[7] Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy [J].

Bart, BA ;

Shaw, LK ;

McCants, CB ;

Fortin, DF ;

Lee, KL ;

Califf, RM ;

OConnor, CM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) :1002-1008

[8] Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance - Are they interchangeable? [J].

Bellenger, NG ;

Burgess, MI ;

Ray, SG ;

Lahiri, A ;

Coats, AJS ;

Cleland, JGF ;

Pennell, DJ .

EUROPEAN HEART JOURNAL, 2000, 21 (16) :1387-1396

[9] Identification of viable myocardium [J].

Bonow, RO .

CIRCULATION, 1996, 94 (11) :2674-2680

[10]

Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI [10.1016/j.hrthm.2008.04.014, 10.1016/j.jacc.2008.05.007]

← 1 2 3 4 5 6 7 →